Diabetic Neuropathy Topical Treatment

• Status: Unknown status
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparative study of efficacy and safety of ketamine, clonidine, mixture of both and placebo in patients with diabetic neuropathic pain

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Irmandade da Santa Casa de Misericordia de Sao Paulo
• Treatments: Clonidine; Ketamine

Criteria

Inclusion Criteria:

• Diabetes Mellitus type I or II

• Mono or polyneuropathy

• Treatment with Tricyclic Antidepressant, Carbamazepine during 3 weeks at least

• Preserved cognition

Exclusion Criteria:

• Ulcerative or infection or vesicle lesion in pain site

• Pregnancy

• Breast feeding